Journal of Diabetes & Metabolism

ISSN - 2155-6156

Juan C Jaen

Juan C Jaen

ChemoCentryx Inc, Mountain View, USA


Juan C. Jaen, Ph.D. has served as our Chief Scientific Officer since February 2010. From January 2007 to February 2010, Dr. Jaen served as our Senior Vice President, Drug Discovery. From 1996 to 2006, Dr. Jaen was employed at Tularik, a biotechnology company, and then Amgen Inc., a pharmaceutical company (following Tularik's acquisition by Amgen in 2004), most recently serving as Vice President of Chemistry. From 1983 to 1996, Dr. Jaen was employed at Parke-Davis/Warner-Lambert, a pharmaceutical company, most recently as Chemistry Director, with responsibility for the neurodegenerative disease research area. Dr. Jaen received his B.S. from the Universidad Complutense in Madrid, Spain and holds a Ph.D. in organic chemistry from the University of Michigan.

Research Interest

Acute Pancreatitis, Acute Pancreatitis Symptoms, Adrenal Disorders, Advanced Type 1 Diabetes Treatment, Advanced Type 2 Diabetes Treatment, Advances in Steroids Detection, Advances in Steroids Treatment

Relevant Topics